TesoRx Pharma, LLC, is a pharmaceuticals company focused on rapidly developing and commercializing pharmaceutical products in specialty and niche markets with significant sales potential. The company's initial product is a first-in-class oral formulation of unmodified testosterone, TSX-002, which uses a unique delivery mechanism and patented proliposomal formulation to address the first-pass metabolic challenges inherent with oral testosterone delivery.
